x
Help Us Guide You Better
best online ias coaching in india
2022-03-29

Download Pdf

banner

Science & Technology
www.livemint.com

Sputnik V became world’s first COVID vaccine with proven efficacy for people living with HIV, a new study showed. The study has been published by The Lancet.  

The data presented are the first scientific results on the preventive efficacy of a COVID vaccine to protect against infection in people living with HIV (PLWH). Based on data from more than 24,000 HIV+ patients in Moscow on antiretroviral therapy (ART), Sputnik V’s efficacy was 79%.

The vaccine’s efficacy against hospitalization was more than 90%. Sputnik V is also more than 97% effective against development of moderate or severe disease among PLWH. The analysis was conducted by the Gamaleya Center and Moscow City Center for AIDS Prevention and Control.

Authors of the study also note that full immunization with Sputnik V in HIV+ patients resulted in a 3.3-fold reduction of COVID-19 infections compared with unvaccinated ones. 

As the data by WHO had previously shownthat more than 23% of HIV+ people hospitalized with COVID, died, the study published in The Lancet suggests Sputnik V is the ultimate solution for vulnerable groups, including in high HIV-prevalence countries.

Download the App to get 14 days of unlimited access to Mint Premium absolutely free!

Log in to our website to save your bookmarks. It'll just take a moment.

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.

Your session has expired, please login again.

You are now subscribed to our newsletters. In case you can’t find any email from our side, please check the spam folder.

This is a subscriber only feature Subscribe Now to get daily updates on WhatsApp

END
© Zuccess App by crackIAS.com